Takashi Fujita, 2004
Rey Panetteiri, 2003
Naofumi Mukaida, Division of Molecular Bioregulation, Cancer Research Institute Kanazawa University, Japan., 2003
Marc Hershenson, Department of Pediatrics and Communicable Diseases University of Michigan, 2003
Malcolm Johnson, Respiratory ScienceGlaxoSmithKline R&D, 2001
Manipulating the innate immune response to rhinovirus infection: implications for asthma exacerbations, Leiden University Medical Centre, Leiden University Medical Centre, 2016
Signalling pathways in rhinovirus infection, MRC Center for Inflammation, University of Edinburgh, MRC Center for Inflammation, University of Edinburgh, 2012
Virus induced asthma exacerbations, Pfizer Ltd, Sandwich UK, Pfizer Ltd, Sandwich UK, 2009
Understanding the molecular biology of human rhinovirus infection: Towards better treatments for virus-induced asthma exacerbation., Hammersmith Hospital, Imperial College London, London, UK,, Hammersmith Hospital, Imperial College London, London, UK,, 2006
Research Student Supervision
Gielen,V, Role of Suppressor of cytokine signalling 1 and 3 in Rhinovirus infection in vitro and in vivo
Haas,JJ, Role of TRAF6 and TAK1 in rhinovirus induced chemokine gene expression and airway neutrophilia in vitro and in vivo.
Porter,J, The anti-viral effects of Azithromycin and other novel macrolides
Porter,J, The innate anti-viral effects of Azithromycin and other novel macrolides
Slater,L, The regulation of human rhinovirus induced type I interferon-beta, type III interferon-lambda and pro-inflammatory cytokine gene expression in normal human bronchial epithelial cells
Sykes,A, Characterising the molecular defect in interferon production in asthma. Pathogen recognition receptors and interferon responses to rhinovirus in asthma.